Atrial Fibrillation Paroxysmal Clinical Trials
4 recruiting trials for Atrial Fibrillation Paroxysmal. Eligibility criteria explained in plain English.
TrialFinderData lists 4 Atrial Fibrillation Paroxysmal clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Pulse Biosciences, Inc. (1), University of California, San Francisco (1), Liverpool John Moores University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is CellFX nsPFA Cardiac Catheter System (device, 1 trial), followed by Alcohol Consumption Randomized Instructions, Biofeedback intervention.
Track Atrial Fibrillation Paroxysmal trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
The objective of this study is to demonstrate the safety and effectiveness of the CellFX nano-second Pulsed Field Ablation (nsPFA) Cardiac Catheter Ablation System in treating...
Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
The goal of this study is to assess the short-term effects of minimal and moderate drinking on atrial fibrillation (AFib) episodes in a real-world population diagnosed with...
Biofeedback Intervention for Paroxysmal Atrial Fibrillation
This project aims to bridge the gap between technology and healthcare by developing a biofeedback intervention that enables daily monitoring of atrial fibrillation episodes and...
The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial Fibrillation
The goal of this clinical trial is to compare the effect of pulmonary vein isolation on atrial function between pulse-field and cryoablation in patients over the age of 18 with...
Explore Other Conditions
Frequently Asked Questions
There are currently 4 clinical trials for Atrial Fibrillation Paroxysmal, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Atrial Fibrillation Paroxysmal, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Atrial Fibrillation Paroxysmal, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.